Cargando…

Age‐stratified longitudinal study of Alzheimer's and vascular dementia patients

INTRODUCTION: Similar symptoms, comorbidities and suboptimal diagnostic tests make the distinction between different types of dementia difficult, although this is essential for improved work‐up and treatment optimization. METHODS: We calculated temporal disease trajectories of earlier multi‐morbidit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jørgensen, Isabella Friis, Aguayo‐Orozco, Alejandro, Lademann, Mette, Brunak, Søren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Featured Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383608/ https://www.ncbi.nlm.nih.gov/pubmed/32342671 http://dx.doi.org/10.1002/alz.12091

Ejemplares similares

Disease trajectory browser for exploring temporal, population-wide disease progression patterns in 7.2 million Danish patients
por: Siggaard, Troels, et al.
Publicado: (2020)

Comorbidity landscape of the Danish patient population affected by chromosome abnormalities
por: Jørgensen, Isabella Friis, et al.
Publicado: (2019)

Optimizing drug selection from a prescription trajectory of one patient
por: Aguayo-Orozco, Alejandro, et al.
Publicado: (2021)

Time-ordered comorbidity correlations identify patients at risk of mis- and overdiagnosis
por: Jørgensen, Isabella Friis, et al.
Publicado: (2021)

Development of Written Materials for Participants in an Alzheimer's Disease and Related Dementias Screening Trial
por: Head, Katharine J, et al.
Publicado: (2022)

Expanding the scope of health disparities research in Alzheimer's disease and related dementias: Recommendations from the “Leveraging Existing Data and Analytic Methods for Health Disparities Research Related to Aging and Alzheimer's Disease and Related Dementias” Workshop Series
por: Akushevich, Igor, et al.
Publicado: (2023)

Central pharmacodynamic activity of solanezumab in mild Alzheimer's disease dementia
por: Willis, Brian A., et al.
Publicado: (2018)

Preclinical Alzheimer's disease and longitudinal driving decline
por: Roe, Catherine M., et al.
Publicado: (2016)

Neuropsychiatric symptoms in patients with dementia and the longitudinal costs of informal care in the Cache County population
por: Rattinger, Gail B., et al.
Publicado: (2019)

Analysis of Time-Series Gene Expression Data to Explore Mechanisms of Chemical-Induced Hepatic Steatosis Toxicity
por: Aguayo-Orozco, Alejandro, et al.
Publicado: (2018)

Plasma hydrogen sulfide: A biomarker of Alzheimer's disease and related dementias
por: Disbrow, Elizabeth, et al.
Publicado: (2021)

Cognitive measures lacking in EHR prior to dementia or Alzheimer's disease diagnosis
por: Maserejian, Nancy, et al.
Publicado: (2021)

Visualising disease trajectories from population-wide data
por: Hjaltelin, Jessica Xin, et al.
Publicado: (2023)

Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial
por: Herring, W. Joseph, et al.
Publicado: (2020)

A metabolite panel that differentiates Alzheimer's disease from other dementia types
por: Jia, Longfei, et al.
Publicado: (2021)

Body brain life: A randomized controlled trial of an online dementia risk reduction intervention in middle-aged adults at risk of Alzheimer's disease
por: Anstey, Kaarin J., et al.
Publicado: (2015)

Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis
por: Ramsey, Christine M., et al.
Publicado: (2017)

Controlling for selective dropout in longitudinal dementia data: Application to the SveDem registry
por: Handels, Ron, et al.
Publicado: (2020)

Population-wide analysis of hospital laboratory tests to assess seasonal variation and temporal reference interval modification
por: Muse, Victorine P., et al.
Publicado: (2023)

Rates of longitudinal change in (18)F‐flortaucipir PET vary by brain region, cognitive impairment, and age in atypical Alzheimer's disease
por: Phillips, Jeffrey S., et al.
Publicado: (2021)

Sex-specific composite scales for longitudinal studies of incipient Alzheimer’s disease
por: Banks, Sarah J., et al.
Publicado: (2019)

Alzheimer's disease progression model using disability assessment for dementia scores from bapineuzumab trials
por: Xu, Steven X., et al.
Publicado: (2015)

Epigenetic conditioning induces intergenerational resilience to dementia in a mouse model of vascular cognitive impairment
por: Belmonte, Krystal Courtney D., et al.
Publicado: (2022)

Power analysis to detect treatment effects in longitudinal clinical trials for Alzheimer's disease
por: Huang, Zhiyue, et al.
Publicado: (2017)

MAPT haplotype–stratified GWAS reveals differential association for AD risk variants
por: Strickland, Samantha L., et al.
Publicado: (2020)

Erratum to “Socially Stratified Epigenetic Profiles Are Associated With Cognitive Functioning in Children and Adolescents”
Publicado: (2023)

Patient Experience With Vascular Access Management Informs Satisfaction With Overall Hospitalization Experience
por: Omkar Prasad, Rohini, et al.
Publicado: (2022)

Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease
por: Libiger, Ondrej, et al.
Publicado: (2021)

Inferior parietal transcranial direct current stimulation with training improves cognition in anomic Alzheimer's disease and frontotemporal dementia
por: Roncero, Carlos, et al.
Publicado: (2017)

sAOP: linking chemical stressors to adverse outcomes pathway networks
por: Aguayo-Orozco, Alejandro, et al.
Publicado: (2019)

Efficacy and safety of the compound Chinese medicine SaiLuoTong in vascular dementia: A randomized clinical trial
por: Jia, Jianping, et al.
Publicado: (2018)

Reducing Risks and Improving Vascular Access Outcomes
por: Morrell, Elizabeth
Publicado: (2020)

A phase 2 randomized, controlled trial of the α7 agonist ABT-126 in mild-to-moderate Alzheimer's dementia
por: Gault, Laura M., et al.
Publicado: (2015)

Opioid use and the presence of Alzheimer's disease and related dementias among elderly Medicare beneficiaries diagnosed with chronic pain conditions
por: Shen, Chan, et al.
Publicado: (2018)

Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: A phase 1 clinical trial
por: Kim, Hee Jin, et al.
Publicado: (2015)

Healthcare costs of dementia diseases before, during and after diagnosis: Longitudinal analysis of 17 years of Swedish register data
por: Persson, Sofie, et al.
Publicado: (2022)

The risk of dementia after coronary artery bypass grafting in relation to age and sex
por: Giang, Kok Wai, et al.
Publicado: (2021)

Comparison of serum neurodegenerative biomarkers among hospitalized COVID‐19 patients versus non‐COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementia
por: Frontera, Jennifer A., et al.
Publicado: (2022)

Difference in the Standard and Novel Lipid Profile Parameters Between Patients With Alzheimer’s Disease and Vascular Dementia Stratified by the Degree of Cognitive Impairment
por: Zaciragic, Asija, et al.
Publicado: (2022)

Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease
por: Wang, Guoqiao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_is883ubbba0er8iimppfokchi5